Singapore Pharmaceuticals and Healthcare Report Q2 2015

BMI Research
February 18, 2015
132 Pages - SKU: BMI5470841
Countries covered: Singapore

Singapore Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Singapore will remain a highly attractive manufacturing base for international pharmaceuticalcompanies due to minimal levels of operational risks and the government's support for the industry. Thepharmaceutical industry has been a key pillar of the country's economy and we believe its importance willcontinue to grow as traditional drivers such as electronic manufacturing slow.

Headline Expenditure Projections

Pharmaceuticals: SGD1.041bn (USD822mn) in 2014 to SGD1.097bn (USD836mn) by 2015; +5.4% inlocal currency terms and +1.7% in USD terms.

Healthcare: SGD19.31bn (USD15.24bn) in 2014 to SGD20.97bn (USD15.97bn) by 2015; +8.6% inlocal currency terms and +4.8% in USD terms.



More Prescription Drugs reports by BMI Research

Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015BMI View: Zimbabwe's Treasury has failed to assign sufficient funds to the health sector in its 2015 National Budget, ...
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015BMI View: The ageing population will have an unprecedented impact on the demand of healthcare and therapeutics in ...
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015BMI View: Access to healthcare in Sudan and South Sudan is poor and drug shortages are ...
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015BMI View: Sri Lanka's strong pharmaceutical market is backed by a committed government and plans to deliver improved ...
See all reports like this >>

More Singapore Prescription Drugs reports

Singapore Pharmaceutical Industry Report - 2014 by Emerging Markets Direct Reports
Singapore Pharmaceutical Industry Report - 2014This report profiles Singapore’s pharmaceutical industry, analyzing sector size and performance, competitive landscape, recent development in the industry as well ...
Singapore Healthcare Industry 2H12 by Emerging Markets Direct Reports
Singapore: Healthcare covers the Asia-Pacific overview, general overview of Singapore, and Singapore healthcare industry including social development and healthcare services. It also covers the market ...
Antibiotics Market in Singapore to 2016 by Global Research & Data Services Oy
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Singapore. The study provides essential market ...
The Pharmaceutical Market: Singapore by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!